Patient Guide: A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 38 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT03075696
Status: 🟢 Enrolling Now
Condition: Non-Hodgkin's Lymphoma
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 38 locations across the country.

Top locations include:
  • • Harvey, Illinois
  • • Ann Arbor, Michigan
  • • Saint Louis, Missouri
  • • And 35 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma - Join Clinical Trial NCTNCT03075696

How to Join This Clinical Trial - NCTNCT03075696

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Non-Hodgkin's Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Hodgkin's Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Hodgkin's Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT03075696 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 38 locations. Find a study site near you:

Clinical Research Site

Harvey, Illinois 60426 - United States

Status: WITHDRAWN

Clinical Research Site

Ann Arbor, Michigan 48109-0934 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Saint Louis, Missouri 63110 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10029 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

New York, New York 10065 - United States

Status: COMPLETED

Clinical Research Site

Pittsburgh, Pennsylvania 15212 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Salt Lake City, Utah 84112 - United States

Status: WITHDRAWN

Clinical Research Site

Seattle, Washington 98104 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Randwick, New South Wales 2031 - Australia

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Melbourne, Victoria 3000 - Australia

Status: RECRUITING

And 28 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Non-Hodgkin's Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships